+
Cabinet Clears Rs 15 Billion Biomedical Research Career Phase III
ECONOMY & POLICY

Cabinet Clears Rs 15 Billion Biomedical Research Career Phase III

The Union Cabinet chaired by Prime Minister Narendra Modi has approved the continuation of the Biomedical Research Career Programme (BRCP) Phase III, a joint initiative of the Department of Biotechnology (DBT), Government of India, and the Wellcome Trust (WT), United Kingdom. The programme will run from 2025–26 to 2030–31, with an additional six years (2031–32 to 2037–38) to service fellowships and grants, at a total cost of Rs 15 billion, of which DBT will contribute Rs 10 billion and WT Rs 5 billion.

Launched in 2008–09 through the DBT/Wellcome Trust India Alliance, the BRCP has been instrumental in supporting world-class biomedical research in India. Phase II was rolled out in 2018–19 with an expanded portfolio, and Phase III will build on this foundation to nurture scientific talent, foster translational innovation, and reduce regional disparities in research capacity.

Phase III will introduce:
  • Early Career and Intermediate Fellowships in basic, clinical and public health, tailored for formative stages of scientists.
  • Collaborative Grants, including Career Development and Catalytic Collaborative Grants for early and mid-senior researchers with strong track records.
  • Research Management Programme to strengthen core research efforts, mentorship, networking, public engagement and international collaborations.

The programme aims to train over 2,000 students and postdoctoral fellows, deliver high-impact publications, enable patentable discoveries, and provide stronger support for women researchers (10–15 per cent increase). It also targets 25–30 per cent of collaborative programmes advancing to Technology Readiness Level (TRL) 4 or above, while expanding engagement in Tier-2 and Tier-3 regions.

Phases I and II established India as an emerging hub for biomedical sciences of global standing. Phase III, aligned with Viksit Bharat goals, will strengthen India’s biomedical research ecosystem, enhance innovation, and cement its place in the global knowledge economy.

The Union Cabinet chaired by Prime Minister Narendra Modi has approved the continuation of the Biomedical Research Career Programme (BRCP) Phase III, a joint initiative of the Department of Biotechnology (DBT), Government of India, and the Wellcome Trust (WT), United Kingdom. The programme will run from 2025–26 to 2030–31, with an additional six years (2031–32 to 2037–38) to service fellowships and grants, at a total cost of Rs 15 billion, of which DBT will contribute Rs 10 billion and WT Rs 5 billion.Launched in 2008–09 through the DBT/Wellcome Trust India Alliance, the BRCP has been instrumental in supporting world-class biomedical research in India. Phase II was rolled out in 2018–19 with an expanded portfolio, and Phase III will build on this foundation to nurture scientific talent, foster translational innovation, and reduce regional disparities in research capacity.Phase III will introduce:Early Career and Intermediate Fellowships in basic, clinical and public health, tailored for formative stages of scientists.Collaborative Grants, including Career Development and Catalytic Collaborative Grants for early and mid-senior researchers with strong track records.Research Management Programme to strengthen core research efforts, mentorship, networking, public engagement and international collaborations.The programme aims to train over 2,000 students and postdoctoral fellows, deliver high-impact publications, enable patentable discoveries, and provide stronger support for women researchers (10–15 per cent increase). It also targets 25–30 per cent of collaborative programmes advancing to Technology Readiness Level (TRL) 4 or above, while expanding engagement in Tier-2 and Tier-3 regions.Phases I and II established India as an emerging hub for biomedical sciences of global standing. Phase III, aligned with Viksit Bharat goals, will strengthen India’s biomedical research ecosystem, enhance innovation, and cement its place in the global knowledge economy.

Next Story
Infrastructure Transport

Lucknow Metro East-West Corridor Consultancy Contract Awarded

The Uttar Pradesh Metro Rail Corporation has awarded the first construction-related consultancy contract for the Lucknow Metro East West Corridor to a joint venture of AYESA Ingenieria Arquitectura SAU and AYESA India Pvt Ltd. The firm was declared the lowest bidder for the Detailed Design Consultant contract for Lucknow Metro Line-2 under Phase 1B and the contract was recommended following the financial bid. The contract is valued at Rs 159.0 million (mn), covering design services for the corridor. Lucknow Metro Line-2 envisages the construction of an 11.165 kilometre corridor connecting Cha..

Next Story
Infrastructure Urban

Div Com Kashmir Urges Fast Tracking Of Jhelum Water Transport Project

The Divisional Commissioner of Kashmir has called for the fast-tracking of the Jhelum water transport project, urging district administrations and relevant agencies to accelerate planning and clearances. In a meeting convened at the divisional headquarters, the commissioner instructed officials from irrigation, public health engineering and municipal departments to prioritise the project and coordinate survey and design work. The directive emphasised removal of administrative bottlenecks and close monitoring to ensure timely mobilisation of resources and contractors. Officials were told to in..

Next Story
Infrastructure Urban

Interarch Reports Strong Q3 And Nine Month Results

Interarch Building Solutions Limited reported unaudited results for the third quarter and nine months ended 31 December 2025, recording strong revenue growth driven by execution and a robust order book. Net revenue for the third quarter rose by 43.7 per cent to Rs 5.225 billion (bn), compared with Rs 3.636 bn a year earlier, reflecting heightened demand in pre-engineered building projects. The company’s total order book as at 31 January 2026 stood at Rs 16.85 bn, supporting near-term visibility. EBITDA excluding other income for the quarter increased by 43.2 per cent to Rs 503 million (mn),..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Open In App